{
 "as_of": "2026-11-06",
 "cmr": "uk-cm-kg/AIM/FARN",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# FARON PHARMACEUTICALS OY (AIM: FARN) — research page\n\nAs of 2026-11-06 · uk-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is FARON PHARMACEUTICALS OY, listed on AIM under ticker FARN, ISIN FI4000153309, LEI 7437009H31TO1DC0EB42. Its security type is Corporate, its segment is ASQ1, its sector is Pharmaceuticals and Biotechnology [201030], and its jurisdiction is Finland (FI). The record holds its listing status as listed, not halted.\n\n## The disclosure read\n\nThe record holds 77 filings in the twelve months to 2026-11-06, across 60 filing days. The filings are 67 regulatory announcements, 7 director dealings, 2 financial statements and 1 halt and resume. The median gap between filing days is 3 days. The latest filing is a regulatory announcement dated 2026-11-04, 2 days before the record date. On AIM the median filings count is 33.5, the median cadence gap is 7.0 days and the median latency is 4 days across 594 issuers. In the sector the median filings count is 42, the median cadence gap is 6.0 days and the median latency is 4.0 days across 51 issuers.\n\n## Auditor\n\nThe auditor of record is not on the record. The auditor's location is not on the record. Auditor changes are not on the record, as the market's register has no lifecycle type map yet.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record, as the market's register has no lifecycle type map yet. The halt flag reads listed, not halted.\n\n## Orderability\n\nFor elective professional client the outcome is signal ACM-200, determinable. For eligible counterparty the outcome is signal ACM-200, determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nThe issuer's investor-relations page names 9 research houses: Kempen, Carnegie, Redeye, Inderes, H.C.WAINWRIGHT&CO, Peel Hunt, Kepler Chevreaux, Panmure Gordon and Stifel Research.\n\n## Open research\n\nNo openly published research notes were found for the issuer.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nNo issuer years are sealed. The market's vintage is not sealed and no earliest sealed date is held. The live record began 2026-09-11. The years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.\n\n## Sources\n\n9 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange)\n- https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/FARN (identity.isin)\n- https://api.gleif.org/api/v1/lei-records/7437009H31TO1DC0EB42 (identity.jurisdiction)\n- https://www.londonstockexchange.com/stock/FARN/faron-pharmaceuticals-oy/company-page (identity.sector)\n- https://mcp.uk-cm-kg.ai/events/AIM/FARN (the disclosure lines)\n- https://marketsecurities.fca.org.uk/officiallist (the halt flag)\n- https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://faron.com/investors/faron-as-an-investment/forecasts-and-analysis-analysts/ (coverage)\n- https://mcp.uk-cm-kg.ai/record/AIM/FARN (the record)\n",
 "market": "UK",
 "node": "uk-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": "2026-09-11",
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "6 years are sealed in the UK store; their Replay split is not built, so the as-of door answers not_sealed and the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false,
   "store_years_sealed_not_served": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ]
  },
  "auditor": {
   "auditor": {
    "market": "UK",
    "reason": "none found",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "UK",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "UK",
    "state": "not_on_record"
   },
   "changes": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "uk-cm-kg/AIM/FARN",
  "coverage": {
   "count": 9,
   "houses": [
    {
     "analyst": "Chiara Montironi",
     "house": "Kempen",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://faron.com/investors/faron-as-an-investment/forecasts-and-analysis-analysts/",
     "state": "sourced"
    },
    {
     "analyst": "Klas Palin",
     "house": "Carnegie",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://faron.com/investors/faron-as-an-investment/forecasts-and-analysis-analysts/",
     "state": "sourced"
    },
    {
     "analyst": "Kevin Sule",
     "house": "Redeye",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://faron.com/investors/faron-as-an-investment/forecasts-and-analysis-analysts/",
     "state": "sourced"
    },
    {
     "analyst": "Antti Siltanen",
     "house": "Inderes",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://faron.com/investors/faron-as-an-investment/forecasts-and-analysis-analysts/",
     "state": "sourced"
    },
    {
     "analyst": "Patrick R, Trucchio",
     "house": "H.C.WAINWRIGHT&CO",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://faron.com/investors/faron-as-an-investment/forecasts-and-analysis-analysts/",
     "state": "sourced"
    },
    {
     "analyst": "Miles Dixon",
     "house": "Peel Hunt",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://faron.com/investors/faron-as-an-investment/forecasts-and-analysis-analysts/",
     "state": "sourced"
    },
    {
     "analyst": "Jon Berggren",
     "house": "Kepler Chevreaux",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://faron.com/investors/faron-as-an-investment/forecasts-and-analysis-analysts/",
     "state": "sourced"
    },
    {
     "analyst": "Julie Simmonds",
     "house": "Panmure Gordon",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://faron.com/investors/faron-as-an-investment/forecasts-and-analysis-analysts/",
     "state": "sourced"
    },
    {
     "house": "Stifel Research",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://faron.com/investors/faron-as-an-investment/forecasts-and-analysis-analysts/",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://faron.com/investors/faron-as-an-investment/forecasts-and-analysis-analysts/",
     "result": "read: 9 of 18 named houses found on the page"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": "not stated on the page read",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 594,
     "median_cadence_gap_days": 7,
     "median_filings": 33.5,
     "median_latency_days": 4,
     "name": "AIM"
    },
    "sector": {
     "issuers": 51,
     "median_cadence_gap_days": 6,
     "median_filings": 42,
     "median_latency_days": 4,
     "name": "Pharmaceuticals and Biotechnology [201030]"
    }
   },
   "by_type": {
    "director_dealing": 7,
    "financial_statement": 2,
    "halt_resume": 1,
    "regulatory_announcement": 67
   },
   "cadence_median_gap_days": 3,
   "filing_days": 60,
   "filings": 77,
   "latency_days": 2,
   "latest": [
    {
     "category": null,
     "date": "2026-11-04",
     "source": "https://www.investegate.co.uk/announcement/mfn/faron-pharmaceuticals-oy-di---farn/faron-announces-five-ash-2026-abstracts-spann-/9858661",
     "title": "Faron Announces Five ASH 2026 Abstracts Spann...",
     "type": "regulatory_announcement"
    },
    {
     "category": null,
     "date": "2026-10-06",
     "source": "https://www.investegate.co.uk/announcement/mfn/faron-pharmaceuticals-oy-di---farn/composition-of-faron-pharmaceutical-s-shareho-/9807643",
     "title": "Composition of Faron Pharmaceutical’s Shareho...",
     "type": "regulatory_announcement"
    },
    {
     "category": null,
     "date": "2026-09-07",
     "source": "https://www.investegate.co.uk/announcement/mfn/faron-pharmaceuticals-oy-di---farn/faron-pharmaceuticals-ltd-holding-s-in-comp-/9759617",
     "title": "FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMP...",
     "type": "regulatory_announcement"
    },
    {
     "category": null,
     "date": "2026-09-04",
     "source": "https://www.investegate.co.uk/announcement/mfn/faron-pharmaceuticals-oy-di---farn/faron-pharmaceuticals-ltd-holding-s-in-comp-/9756531",
     "title": "FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMP...",
     "type": "regulatory_announcement"
    },
    {
     "category": null,
     "date": "2026-08-26",
     "source": "https://www.investegate.co.uk/announcement/mfn/faron-pharmaceuticals-oy-di---farn/faron-pharmaceuticals-ltd-half-year-financia-/9740173",
     "title": "Faron Pharmaceuticals Ltd: Half-year financia...",
     "type": "regulatory_announcement"
    }
   ],
   "latest_filing_date": "2026-11-04",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.uk-cm-kg.ai/events/AIM/FARN",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=AIM, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "AIM"
   },
   "isin": {
    "read_by": "LSE instrument reference record (exchange site)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/FARN",
    "state": "sourced",
    "value": "FI4000153309"
   },
   "jurisdiction": {
    "read_by": "GLEIF LEI record (LEI per the LEI column)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://api.gleif.org/api/v1/lei-records/7437009H31TO1DC0EB42",
    "state": "sourced",
    "value": "Finland (FI)"
   },
   "lei": {
    "read_by": "GLEIF name-exact",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://api.gleif.org/api/v1/lei-records/7437009H31TO1DC0EB42",
    "state": "filled",
    "value": "7437009H31TO1DC0EB42"
   },
   "name": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=AIM, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "FARON PHARMACEUTICALS OY"
   },
   "sector": {
    "read_by": "LSE issuer profile (exchange site)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/stock/FARN/faron-pharmaceuticals-oy/company-page",
    "state": "sourced",
    "value": "Pharmaceuticals and Biotechnology [201030]"
   },
   "security_type": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=AIM, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=AIM, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "ASQ1"
   },
   "ticker": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=AIM, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "FARN"
   },
   "website": {
    "read_by": "LSE issuer profile (exchange site)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/stock/FARN/faron-pharmaceuticals-oy/company-page",
    "state": "sourced",
    "value": "www.faron.com"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "UK",
  "node": "uk-cm-kg",
  "numbers_hash": "sha256:75558cf08d68f14123f8c7ba691e1891f5ce49eef99d255f765c56f4359f28a6",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [
    "elective professional client",
    "eligible counterparty"
   ],
   "outcomes": {
    "elective professional client": {
     "determinable": true,
     "signal": "ACM-200"
    },
    "eligible counterparty": {
     "determinable": true,
     "signal": "ACM-200"
    }
   },
   "read": {
    "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group",
    "chapter": "https://mcp.uk-cm-kg.ai/book/aio.json",
    "door": "https://mcp.uk-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "rule_version": "acm-68000/uk/product-governance-fca-prod-sourcebook/r1",
   "section": "uk.aio.v16"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.uk-cm-kg.ai/record/AIM/FARN",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-09",
   "source": "https://marketsecurities.fca.org.uk/officiallist",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:75558cf08d68f14123f8c7ba691e1891f5ce49eef99d255f765c56f4359f28a6",
 "path": "/uk/AIM/FARN",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is FARON PHARMACEUTICALS OY, listed on AIM under ticker FARN, ISIN FI4000153309, LEI 7437009H31TO1DC0EB42. Its security type is Corporate, its segment is ASQ1, its sector is Pharmaceuticals and Biotechnology [201030], and its jurisdiction is Finland (FI). The record holds its listing status as listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 77 filings in the twelve months to 2026-11-06, across 60 filing days. The filings are 67 regulatory announcements, 7 director dealings, 2 financial statements and 1 halt and resume. The median gap between filing days is 3 days. The latest filing is a regulatory announcement dated 2026-11-04, 2 days before the record date. On AIM the median filings count is 33.5, the median cadence gap is 7.0 days and the median latency is 4 days across 594 issuers. In the sector the median filings count is 42, the median cadence gap is 6.0 days and the median latency is 4.0 days across 51 issuers.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is not on the record. The auditor's location is not on the record. Auditor changes are not on the record, as the market's register has no lifecycle type map yet.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "Listing, delisting, name change, domicile change and segment move are not on the record, as the market's register has no lifecycle type map yet. The halt flag reads listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "For elective professional client the outcome is signal ACM-200, determinable. For eligible counterparty the outcome is signal ACM-200, determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The issuer's investor-relations page names 9 research houses: Kempen, Carnegie, Redeye, Inderes, H.C.WAINWRIGHT&CO, Peel Hunt, Kepler Chevreaux, Panmure Gordon and Stifel Research.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found for the issuer.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "No issuer years are sealed. The market's vintage is not sealed and no earliest sealed date is held. The live record began 2026-09-11. The years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "9 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer"
  },
  {
   "for": "identity.isin",
   "source": "https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/FARN"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://api.gleif.org/api/v1/lei-records/7437009H31TO1DC0EB42"
  },
  {
   "for": "identity.sector",
   "source": "https://www.londonstockexchange.com/stock/FARN/faron-pharmaceuticals-oy/company-page"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.uk-cm-kg.ai/events/AIM/FARN"
  },
  {
   "for": "the halt flag",
   "source": "https://marketsecurities.fca.org.uk/officiallist"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.uk-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://faron.com/investors/faron-as-an-investment/forecasts-and-analysis-analysts/"
  },
  {
   "for": "the record",
   "source": "https://mcp.uk-cm-kg.ai/record/AIM/FARN"
  }
 ],
 "title": "FARON PHARMACEUTICALS OY (FARN) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}